171 related articles for article (PubMed ID: 36690931)
1. Identification of prognostic and predictive biomarkers in high-dimensional data with PPLasso.
Zhu W; Lévy-Leduc C; Ternès N
BMC Bioinformatics; 2023 Jan; 24(1):25. PubMed ID: 36690931
[TBL] [Abstract][Full Text] [Related]
2. A variable selection approach for highly correlated predictors in high-dimensional genomic data.
Zhu W; Lévy-Leduc C; Ternès N
Bioinformatics; 2021 Aug; 37(16):2238-2244. PubMed ID: 33617644
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.
Marengo E; Robotti E
World J Gastroenterol; 2014 Oct; 20(37):13325-42. PubMed ID: 25309068
[TBL] [Abstract][Full Text] [Related]
4. Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints.
Gu X; Yin G; Lee JJ
Contemp Clin Trials; 2013 Nov; 36(2):642-50. PubMed ID: 24075829
[TBL] [Abstract][Full Text] [Related]
5. Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.
Ternès N; Rotolo F; Michiels S
BMC Med Res Methodol; 2017 May; 17(1):83. PubMed ID: 28532387
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing prognostic and predictive biomarkers: an information theoretic approach.
Sechidis K; Papangelou K; Metcalfe PD; Svensson D; Weatherall J; Brown G
Bioinformatics; 2018 Oct; 34(19):3365-3376. PubMed ID: 29726967
[TBL] [Abstract][Full Text] [Related]
7. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
8. Status of Immune Oncology: Challenges and Opportunities.
Cesano A; Marincola FM; Thurin M
Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces.
Ternès N; Rotolo F; Heinze G; Michiels S
Biom J; 2017 Jul; 59(4):685-701. PubMed ID: 27862181
[TBL] [Abstract][Full Text] [Related]
10. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
11. Precision Lasso: accounting for correlations and linear dependencies in high-dimensional genomic data.
Wang H; Lengerich BJ; Aragam B; Xing EP
Bioinformatics; 2019 Apr; 35(7):1181-1187. PubMed ID: 30184048
[TBL] [Abstract][Full Text] [Related]
12. Divining responder populations from survival data.
Rahman R; Ventz S; Fell G; Vanderbeek AM; Trippa L; Alexander BM
Ann Oncol; 2019 Jun; 30(6):1005-1013. PubMed ID: 30860592
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review.
Al-Tashi Q; Saad MB; Muneer A; Qureshi R; Mirjalili S; Sheshadri A; Le X; Vokes NI; Zhang J; Wu J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175487
[TBL] [Abstract][Full Text] [Related]
14. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
15. Semiparametric models of time-dependent predictive values of prognostic biomarkers.
Zheng Y; Cai T; Stanford JL; Feng Z
Biometrics; 2010 Mar; 66(1):50-60. PubMed ID: 19397579
[TBL] [Abstract][Full Text] [Related]
16. Evolution of predictive risk factor analysis for chemotherapy-related toxicity.
Hertz DL; Lustberg MB; Sonis S
Support Care Cancer; 2023 Sep; 31(10):601. PubMed ID: 37773300
[TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.
Halligan S; Boone D; Archer L; Ahmad T; Bloom S; Rodriguez-Justo M; Taylor SA; Mallett S
Health Technol Assess; 2021 Jul; 25(45):1-66. PubMed ID: 34225839
[TBL] [Abstract][Full Text] [Related]
18. Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies.
Huang M; Hobbs BP
Stat Methods Med Res; 2019 Sep; 28(9):2820-2833. PubMed ID: 30037304
[TBL] [Abstract][Full Text] [Related]
19. Selecting predictive biomarkers from genomic data.
Frommlet F; Szulc P; König F; Bogdan M
PLoS One; 2022; 17(6):e0269369. PubMed ID: 35709188
[TBL] [Abstract][Full Text] [Related]
20. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
